Blue Jet Healthcare intimates exchange of analyst call on May 25, 2026, to discuss audited standalone Q4 and FY26 results.
Management participants include MD Shiven Arora, COO V.K. Singh, CFO Ganesh Karuppannan, and Deputy CFO Sanjay Sinha.
Call access provided via universal toll-free numbers and DiamondPass™ link for investors and analysts.
Company operates as CDMO specializing in contrast media intermediates and high-intensity sweeteners for global clients.